Stockreport

AN2 slashes staff by 50% after lead antibiotic flunks in Phase II/III trial [Yahoo! Finance]

Allakos Inc.  (ALLK) 
Last allakos inc. earnings: 11/12 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.allakos.com/investor-relations
PDF The antibiotic's development suffered a major setback a few months back, after AN2 voluntarily stopped enrolment in the Phase III portion of the trial. The decision fol [Read more]